A detailed history of Inspire Investing, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Inspire Investing, LLC holds 27,474 shares of PCRX stock, worth $456,068. This represents 0.04% of its overall portfolio holdings.

Number of Shares
27,474
Previous 12,336 122.71%
Holding current value
$456,068
Previous $352,000 17.33%
% of portfolio
0.04%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$11.7 - $28.46 $177,114 - $430,827
15,138 Added 122.71%
27,474 $413,000
Q2 2024

Aug 12, 2024

BUY
$25.5 - $31.51 $5,227 - $6,459
205 Added 1.69%
12,336 $352,000
Q1 2024

May 07, 2024

BUY
$27.7 - $35.48 $18,697 - $23,948
675 Added 5.89%
12,131 $354,000
Q4 2023

Feb 12, 2024

BUY
$26.32 - $34.31 $40,164 - $52,357
1,526 Added 15.37%
11,456 $386,000
Q3 2023

Oct 26, 2023

BUY
$30.68 - $40.09 $63,906 - $83,507
2,083 Added 26.55%
9,930 $304,000
Q2 2023

Jul 31, 2023

BUY
$36.12 - $47.5 $42,368 - $55,717
1,173 Added 17.58%
7,847 $314,000
Q1 2023

Apr 24, 2023

BUY
$35.53 - $43.38 $21,140 - $25,811
595 Added 9.79%
6,674 $272,000
Q4 2022

Jan 26, 2023

BUY
$38.19 - $57.45 $84,552 - $127,194
2,214 Added 57.28%
6,079 $0
Q3 2022

Nov 07, 2022

BUY
$51.24 - $58.89 $9,633 - $11,071
188 Added 5.11%
3,865 $206,000
Q2 2022

Aug 10, 2022

BUY
$51.49 - $81.64 $29,555 - $46,861
574 Added 18.5%
3,677 $214,000
Q1 2022

Apr 21, 2022

SELL
$60.03 - $76.49 $60,930 - $77,637
-1,015 Reduced 24.65%
3,103 $237,000
Q4 2021

Feb 14, 2022

BUY
$47.97 - $62.21 $197,540 - $256,180
4,118 New
4,118 $248,000
Q4 2021

Feb 03, 2022

SELL
$47.97 - $62.21 $193,175 - $250,519
-4,027 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$54.64 - $61.3 $3,660 - $4,107
67 Added 1.69%
4,027 $226,000
Q2 2021

Aug 10, 2021

BUY
$59.18 - $69.99 $7,101 - $8,398
120 Added 3.13%
3,960 $240,000
Q1 2021

Apr 30, 2021

SELL
$59.31 - $78.82 $237 - $315
-4 Reduced 0.1%
3,840 $269,000
Q4 2020

Feb 12, 2021

BUY
$50.47 - $66.26 $194,006 - $254,703
3,844 New
3,844 $230,000
Q3 2020

Nov 16, 2020

SELL
$51.97 - $63.0 $215,883 - $261,702
-4,154 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$30.8 - $52.47 $44,321 - $75,504
-1,439 Reduced 25.73%
4,154 $218,000
Q1 2020

May 08, 2020

BUY
$28.4 - $50.7 $158,841 - $283,565
5,593 New
5,593 $188,000
Q1 2018

Apr 13, 2018

SELL
$29.98 - $46.35 $38,914 - $60,162
-1,298 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$31.85 - $46.95 $41,341 - $60,941
1,298
1,298 $59,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $761M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.